Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Increases By 417.6%

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) saw a large growth in short interest in the month of July. As of July 31st, there was short interest totaling 296,924 shares, a growth of 417.6% from the July 15th total of 57,363 shares. Approximately 0.6% of the shares of the company are sold short. Based on an average daily volume of 19,111,558 shares, the short-interest ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised shares of Zhengye Biotechnology from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday, July 20th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Institutional Trading of Zhengye Biotechnology

A number of large investors have recently bought and sold shares of the company. XTX Topco Ltd raised its stake in shares of Zhengye Biotechnology by 71.4% in the fourth quarter. XTX Topco Ltd now owns 59,286 shares of the company’s stock valued at $68,000 after buying an additional 24,697 shares during the period. WINTON GROUP Ltd grew its stake in shares of Zhengye Biotechnology by 193.8% during the 4th quarter. WINTON GROUP Ltd now owns 63,297 shares of the company’s stock worth $73,000 after acquiring an additional 41,750 shares during the period. Millennium Management LLC bought a new position in shares of Zhengye Biotechnology during the 3rd quarter worth $38,000. Citadel Advisors LLC purchased a new stake in Zhengye Biotechnology in the 3rd quarter worth about $31,000. Finally, Jane Street Group LLC purchased a new stake in Zhengye Biotechnology in the 2nd quarter worth about $1,158,000.

Zhengye Biotechnology Price Performance

Shares of ZYBT stock traded up $0.01 during trading hours on Friday, hitting $1.53. 40,569 shares of the company were exchanged, compared to its average volume of 2,211,719. The company has a current ratio of 1.14, a quick ratio of 0.82 and a debt-to-equity ratio of 0.03. The firm has a fifty day simple moving average of $1.23 and a 200 day simple moving average of $1.02. Zhengye Biotechnology has a 52-week low of $0.62 and a 52-week high of $13.08.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.